The Trump administration, on the other hand, got even lower scores on how it treated vaccine manufacturing and delivery, with just 43% saying they did an outstanding or decent job.
According to the survey, 59 percent approve of Biden’s performance as president, while 39 percent disapprove.
Biden’s work approval rate has risen slightly from 54% in March and is similar to that of many of his predecessors, including Barack Obama and George H. W. Bush, but it is significantly higher than that of Donald Trump in April 2017.
Views of Biden and his government differ sharply with that of his predecessor.
According to the poll, 46 percent of Americans like the way Biden handles himself as president, 27 percent don’t, and another 27 percent have mixed feelings about his actions.
Furthermore, 44 percent said he improved the sound of democratic dialogue, while 29 percent said he made it worse.
According to the poll, there is a significant distance between him and his predecessor, Trump.
Indeed, only 15% of Americans approved of Trump’s performance as president last year. In both 2020 and 2019, 55 percent of Americans said Trump has changed the national debate in the United States for the worse.
However, the proportion of the electorate who agree with Biden on major topics is similar to the proportion who agreed with Trump last year.
Fewer than half of Americans (44%) said they agree with Biden on all or almost all (13%) or several (31%) of the critical issues confronting the country; 25% said they agree with Biden on a few issues, and 29% said they agree with him on almost no issues. Last year, 42% of Americans said they agreed with Trump on almost all (19%) or several topics (23 percent ).
The administration receives strong marks for treating the manufacturing and delivery of the COVID-19 vaccines, according to a recent nationwide survey conducted by Pew Research Center on the Center’s nationally representative American Trends Panel from April 5-11, 2021 among 5,109 people.
Although a vast majority of Democrats and Democratic-leaning independents (88%) said the administration did an outstanding or decent job handling the vaccine rollout, a slightly smaller majority (55%) of Republicans and Republican leaners said the same.
However, a 55 percent majority of the electorate – including 86 percent of Republicans and almost a third of Democrats – supports the Trump administration’s funding for several pharmaceutical firms’ manufacture of COVID-19 vaccines.